Princy Kashyap

Princy Kashyap

Auto-generated profile, based on publicly available information

Princy Kashyap

Department of Pharmacy, Guru Ghasidas Central University, Koni, Bilaspur-495009, C.G., India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
PSPoonam Sahu
Poonam Sahu
SBShiv Kumar Bhardwaj
Shiv Kumar Bhardwaj
ASAbinash Satapathy
Abinash Satapathy
ASAbhisek Satapathy
Abhisek Satapathy
AKArvind Kumar
Arvind Kumar
MCManisha Chandrakar
Manisha Chandrakar
Omega-3 fatty acids, including alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), are essential polyunsaturated fats known for their vital roles in cardiovascular, neurological, and inflammatory health. Growing awareness of their therapeutic benefits, coupled with sustainability concerns, has intensified research into their natural sources, biosynthesis, pharmacokinetics, and clinical applications. This review provides an integrative synthesis of recent advances in omega-3 fatty acid research, encompassing their sources, bioavailability, sustainability, mechanisms of action, and clinical relevance. Plant-based oils, marine fish, krill, and microalgae remain key natural sources, while innovations such as algal oils and genetically engineered crops present sustainable alternatives. The human conversion of ALA to EPA and DHA is inherently limited due to Δ6-desaturase and elongase enzyme constraints, with efficiency affected by genetic, hormonal, and dietary factors. Bioavailability is influenced by molecular form, with triglyceride, ethyl ester, and phospholipid structures displaying varying absorption and metabolic profiles. Mechanistically, omega-3 fatty acids regulate inflammation, maintain neuronal membrane integrity, and improve vascular function, with emerging evidence suggesting potential anti-cancer effects. Collectively, these insights underscore the significant preventive and therapeutic potential of omega-3 fatty acids and highlight the need for optimizing bioavailability, advancing sustainable production, and personalizing clinical applications to support future nutrition and healthcare strategies. Keywords: Omega-3 fatty acids, Eicosapentaenoic acid, Docosahexaenoic acid , Bioavailability, Sustainable nutrient sources, Clinical nutrition

15 November 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
PSPoonam Sahu
Poonam Sahu
KCKunal Chandrakar
Kunal Chandrakar
PKPrincy Kashyap
Princy Kashyap
MKManoj Kumar
Manoj Kumar
AKArvind Kumar
Arvind Kumar
MCManisha Chandrakar
Manisha Chandrakar
Intranasal nanoparticulate drug delivery systems have received increased attention in pharmaceutical research due to their ability to increase drug bioavailability, bypass the blood-brain barrier (BBB), and provide non-invasive, patient-friendly alternatives to drug administration, particularly for drugs intended for central nervous system (CNS) disorders. Drugs delivered via nasal route can enter the CNS via the olfactory pathway or the trigeminal nerve pathway, enabling access to deeper regions. Intranasal nanoparticulate systems have several pharmacological benefits, including increased bioavailability, a faster onset of action, higher patient compliance, and less systemic adverse effects. Intranasal nanoparticulate drug delivery has shown promise in a variety of therapeutic areas, including Alzheimer's disease, Parkinson's disease, depression, and anxiety. Intranasal vaccinations and antibacterial Nanoparticle are also utilized to treat respiratory and viral illnesses. This technique is thought to be useful in brain-targeted chemotherapeutic drugs for glioblastoma treatment. The authors of this review attempted to investigate the pharmacological features of nanoparticulate drug delivery systems, including their benefits, mechanisms, formulation methodologies, and clinical applications. Keywords: Alzheimer's disease, Drug delivery, Nanoparticle, Nasal route, Neuro inflammation, Parkinson’s disease,

14 January 2026 in The Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PKPrincy Kashyap
Princy Kashyap
MKManoj Kumar
Manoj Kumar
RBRamenani Hari Babu
Ramenani Hari Babu
MGMahesh Kumar Gupta
Mahesh Kumar Gupta